Literature DB >> 17684634

The investigation of parvovirus B19 infection in patients with haematological disorders by using PCR and ELISA techniques.

Tercan Us1, Leyla Ozune, Nilgun Kasifoglu, Yurdanur Akgun.   

Abstract

Parvovirus B19 has a marked tropism for erythroid progenitor cells. This may lead to chronic anemia in predisposed individuals. The purpose of the study was to investigate the frequency of parvovirus B19 infections in patients with diagnosis of haematological disorders. In order to determine the diagnostic use of different markers of parvovirus B19 infection, serum specimens obtained from 79 patients with haematological disorders were tested for specific antibodies and viral DNA through the use of ELISA and PCR techniques. Evidence of parvovirus B19 infection was found in 23/79 (29.1%) patients by demonstrating viral DNA and/or specific IgM antibody. B19 infection was established in 3 of 11 patients with chronic myeloid leukemia, in 3 of 11 acute myeloid leukemia, in 2 of 11 patients with multiple myeloma, in 3 of 8 patients with Hodgkin's lymphoma, in 5 of 10 patients with non-Hodgkin's lymphoma, in 1 of 6 patients with myelodysplastic syndrome, in 4 of 11 patients with chronic lymphocytic leukemia, and in 2 of 11 patients with acute lymphocytic leukemia. In 4 of 23 positive patients, only parvovirus B19 DNA could be detected, while 7 patients were tested positive for both parvovirus B19 DNA and specific IgM. Nine patients were tested positive for both B19 DNA and specific IgG. In the remaining 3 positive patients only specific IgM could be detected. Due to the discrepancies between DNA and IgM results, the diagnostic procedures should include a search for specific DNA by PCR methods if specific IgM has been found to be negative.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17684634     DOI: 10.1590/s1413-86702007000300006

Source DB:  PubMed          Journal:  Braz J Infect Dis        ISSN: 1413-8670            Impact factor:   1.949


  5 in total

1.  Primate Erythroparvovirus 1 Infection in Patients with Hematological Disorders.

Authors:  Stefka Krumova; Ivona Andonova; Radostina Stefanova; Polina Miteva; Galina Nenkova; Judith M Hübschen
Journal:  Pathogens       Date:  2022-04-21

2.  A pilot study on parvovirus B19 infection in paediatric haematological malignancies.

Authors:  Janak Kishore; Manodeep Sen; Ashutosh Kumar; Archana Kumar
Journal:  Indian J Med Res       Date:  2011-04       Impact factor: 2.375

3.  Detection of Parvovirus B19 Infection in Thalasemic Patients in Isfahan Province, Iran.

Authors:  Razieh Nikoozad; Mohammad Reza Mahzounieh; Mohammad Reza Ghorani
Journal:  Jundishapur J Microbiol       Date:  2015-11-08       Impact factor: 0.747

4.  Human parvovirus B19 in patients with beta thalassemia major from Tehran, Iran.

Authors:  Seyed Ali Mohammad Arabzadeh; Farideh Alizadeh; Ahmad Tavakoli; Hamidreza Mollaei; Farah Bokharaei-Salim; Gharib Karimi; Mohammad Farahmand; Helya Sadat Mortazavi; Seyed Hamidreza Monavari
Journal:  Blood Res       Date:  2017-03-27

5.  Aplastic anemia induced by human parvovirus B19 infection in an immunocompetent adult male without prior hematological disorders: A case report.

Authors:  Ayush Mohan Bhattarai; Bishal Dhakal; Pooja Rokaya; Abinash Karki; Shekhar Gurung; Smarika Baral
Journal:  Ann Med Surg (Lond)       Date:  2022-06-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.